NGAL (LCN2) Human shRNA Plasmid Kit (Locus ID 3934)
CAT#: TG311777
LCN2 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 2 publications. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | NGAL (LCN2) Human shRNA Plasmid Kit (Locus ID 3934) |
Locus ID | 3934 |
UniProt ID | P80188 |
Synonyms | 24p3; MSFI; NGAL; p25 |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | LCN2 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 3934). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_005564, NM_005564.1, NM_005564.2, NM_005564.3, NM_005564.4, BC033089, BC033089.1, BM977724, NM_005564.5 |
Summary | This gene encodes a protein that belongs to the lipocalin family. Members of this family transport small hydrophobic molecules such as lipids, steroid hormones and retinoids. The protein encoded by this gene is a neutrophil gelatinase-associated lipocalin and plays a role in innate immunity by limiting bacterial growth as a result of sequestering iron-containing siderophores. The presence of this protein in blood and urine is an early biomarker of acute kidney injury. This protein is thought to be be involved in multiple cellular processes, including maintenance of skin homeostasis, and suppression of invasiveness and metastasis. Mice lacking this gene are more susceptible to bacterial infection than wild type mice. [provided by RefSeq, Sep 2015] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells
,Miyamoto, T;Kashima, H;Yamada, Y;Kobara, H;Asaka, R;Ando, H;Higuchi, S;Ida, K;Mvunta, DH;Shiozawa, T;,
PLoS ONE
,PubMed ID 27168162
[LCN2]
|
Lipocalin 2 attenuates iron-related oxidative stress and prolongs the survival of ovarian clear cell carcinoma cells by up-regulating the CD44 variant
,Yamada, Y;Miyamoto, T;Kashima, H;Kobara, H;,
Free radical Research
,PubMed ID 26729415
[LCN2]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...